Finance

Lists
AQSZF:OTCMKTS
Aequus Pharmaceuticals Inc
$0.00030
0.00%
(0.00) 1D
Oct 14, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AQSZF...
Open
$0.00
High
$0.00
Low
$0.00
Avg. vol.
56.38K
Volume
10.00K
52-wk high
$0.01
52-wk low
$0.00
Beta
-2.52
Shares outstanding
132.63M
No. of employees
12
Open
$0.00
High
$0.00
Low
$0.00
Avg. vol.
56.38K
Volume
10.00K
52-wk high
$0.01
52-wk low
$0.00
Beta
-2.52
Shares outstanding
132.63M
No. of employees
12
News stories
From web sources and news partners
About Aequus Pharmaceuticals Inc
CEO-
Employees12
Founded2013
HeadquartersVancouver, British Columbia, Canada
SectorPharmaceutical industry
Websiteaequuspharma.ca
Previous reports
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Revenue
221.95K
226.54K
218.22K
251.75K
Cost of goods sold
74.90K
90.09K
110.75K
119.68K
Cost of revenue
74.90K
90.09K
110.75K
119.68K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
454.05K
224.01K
199.28K
219.75K
Operating expense
454.05K
224.01K
199.28K
219.75K
Total operating expenses
528.95K
314.09K
310.03K
339.43K
Operating income
-307.00K
-87.55K
-91.81K
-87.68K
Other non operating income
-43.06K
-
-
-
EBT including unusual items
-217.81K
-645.10K
-163.91K
370.48K
EBT excluding unusual items
-421.46K
-159.90K
-163.91K
-147.62K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-217.81K
-645.10K
-163.91K
370.48K
Net profit margin
-98.14%
-284.76%
-75.11%
147.16%
Earnings per share
-
-
-
-
Interest and investment income
2.54K
-
-
-
Interest expense
-71.99K
-69.97K
-70.30K
-58.93K
Net interest expenses
-69.45K
-69.97K
-70.30K
-58.93K
Depreciation and amortization charges
-
-
-
-
EBITDA
-305.55K
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps